Cytiva, part of Danaher Corporation, is a leading global provider of biotechnology solutions and services. The company recently established its first innovation hub in South Korea, located in the Songdo Bio-cluster in Incheon. This 6,100 square-meter facility is designed to support the biopharmaceutical industry in the Asia-Pacific region, with a focus on manufacturing sterile-filtration products. The plant, expected to start operations in 2026, will create 150 local jobs and has plans to expand into virus filtration equipment. This strategic move aims to meet growing demands for advanced therapies, bolstering Cytiva's commitment to sustainability and customer engagement in the region